| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 43 |
| 1 | PREDNISONE | 42 |
| 2 | ASPIRIN | 38 |
| 3 | ASPIRIN 325 MG | 38 |
| 4 | ASPIRIN 81 MG | 38 |
| 5 | METHOTREXATE SODIUM | 36 |
| 6 | LETROZOLE | 35 |
| 7 | CYCLOPHOSPHAMIDE | 33 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 33 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 33 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | 1 | 0.0025 |
| 1 | FLUNISOLIDE | 3 | 0.0020 |
| 2 | GLOFITAMAB | 5 | 0.0018 |
| 3 | VERAPAMIL HYDROCHLORIDE | 7 | 0.0016 |
| 4 | BEPOTASTINE BESILATE | 1 | 0.0016 |
| 5 | BROMOCRIPTINE MESYLATE | 1 | 0.0015 |
| 6 | TEPOTINIB HYDROCHLORIDE | 1 | 0.0014 |
| 7 | L-LYSINE | 1 | 0.0014 |
| 8 | DACOMITINIB | 1 | 0.0013 |
| 9 | 12%AZELAIC ACID | 1 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 88 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 78 |
| 2 | Aromatase Inhibitor [EPC] | 50 |
| 3 | Loop Diuretic [EPC] | 47 |
| 4 | Kinase Inhibitor [EPC] | 46 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 38 |
| 6 | Alkylating Drug [EPC] | 37 |
| 7 | Platinum-based Drug [EPC] | 35 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 34 |
| 9 | Proton Pump Inhibitor [EPC] | 33 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 5 | 0.0012 |
| 1 | Estrogen Receptor Antagonist [EPC] | 26 | 0.0006 |
| 2 | Ergot Derivative [EPC] | 3 | 0.0006 |
| 3 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 1 | 0.0006 |
| 4 | CD33-directed Immunoconjugate [EPC] | 2 | 0.0005 |
| 5 | Aromatase Inhibitor [EPC] | 50 | 0.0004 |
| 6 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 24 | 0.0003 |
| 8 | Calcitonin [EPC] | 1 | 0.0003 |
| 9 | Prostacyclin Receptor Agonist [EPC] | 8 | 0.0003 |